Hope Never Dies

09/16/2026

What if one of the most overlooked parts of cancer care happens after you go to bed?

Sleep isn't just about feeling rested. Research continues to show that healthy circadian rhythms are closely tied not only to fatigue and quality of life, but even to survival outcomes for many cancer patients.

This article from The Block Center explores why protecting your body's natural sleep-wake cycle deserves far more attention than it gets, and why small daily habits may have a bigger impact than many people realize.

Advanced cancer patients receiving chemotherapy or radiation treatments often report suffering from insomnia, daytime sleepiness, fatigue and depression. In fact, experts estimate that as many as 50% of patients dealing with lung and other cancers experience fatigue syndrome, a combination of physic...

09/11/2026

One of the most practical takeaways from Hope Never Dies is not just what patients did differently, but also how they thought differently and vocalized their concerns and input ... especially when engaging with their doctors and understanding their treatment options.

09/07/2026

Cancer fatigue doesn't get nearly the attention it deserves.

It affects up to 99% of people during treatment, yet many patients assume it's just something they have to live with.

The good news is that research has identified strategies that genuinely help, and the one with the strongest evidence surprises a lot of people.

Learn more here:

Jenny Spencer, RN, oncology nurse navigator and cancer exercise specialist, provides clear guidance on understanding and managing cancer-related fatigue.

08/28/2026

Cancer is not only a disease of uncontrolled growth, it is also a disease of disrupted cellular energy and metabolism.

Cancer cells survive by rewiring how they produce and use energy, often operating under constant metabolic stress. These altered bioenergetic states help explain why cancers adapt, behave unpredictably, and resist treatment.

Studying cancer through this metabolic lens provides critical insight into treatment response and resistance - expanding how clinicians and researchers understand cancer beyond genetics alone.

Listen to Dr. Nagourney of the Nagourney Cancer Institute as he weighs in >> https://www.facebook.com/watch/?ref=saved&v=1170969081488758

08/24/2026

One of the survivors featured in shares his experience of battling prostate cancer.

He began his journey with a Gleason Score of 8, indicating a rapidly advancing cancer. With the guidance of Donnie Yance from Mederi Center, he was able to recover with no evidence of disease.

08/19/2026

Human tumor studies are rapidly changing the landscape of cancer treatment.

"We take the patient’s tumor from their surgery and test it for the drugs that are being considered. We don’t just give these drugs because they “might” work. We give these drugs because they “do” work, as confirmed in each patient’s cancer cells."

- Dr. Robert Nagourney of Nagourney Cancer Institute

08/14/2026

A stage 4 cancer diagnosis doesn't have to be a death sentence. Julie's remarkable story is featured on page 11 of .

08/10/2026

Is every "complementary therapy" really the same? Of course not.

This article by Donnie Yance raises an important point: Grouping vastly different approaches into one category oversimplifies both the science and the conversation.

It's a thoughtful reminder that evidence deserves careful review and interpretation, especially when people's lives are involved.

We read with interest the study by Ayoade et al. examining the association between complementary and alternative medicine (CAM) use and survival in breast cancer patients.